Early detection of pancreatic carcinoma

Hematology/Oncology Clinics of North America

Volumn 16, Issue 1, 2002, Pages 37-52

  Rosty, Christophe ^a   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER SCREENING; EARLY DIAGNOSIS; HUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ADENOCARCINOMA; CA-19-9 ANTIGEN; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; HYPERPLASIA; MASS SCREENING; MODELS, BIOLOGICAL; NEOPLASTIC SYNDROMES, HEREDITARY; ONCOGENES; PANCREAS; PANCREATIC JUICE; PANCREATIC NEOPLASMS; PROTEOMICS; SMOKING; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036266050     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(01)00007-7     Document Type: Review

References (110)

1. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: Survival results and observations regarding patterns of failure, radiotherapy dose and CA19 9 levels
2. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins
3. Elevated serum levels of tumor marker CA19 9 in acute cholangitis
4. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
5. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
6. A comparison of selected mRNA and protein abundances in human liver
7. Mesothelin is expressed in the vast majority of adenocarcinomas of the pancreas: Identification of a new cancer marker by serial analysis of gene expression (SAGE)
8. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
9. Endoscopic ultrasound and intraductal ultrasound in the diagnosis of small pancreatic tumors
10. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
11. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis
12. Potentially resectable pancreatic adenocarcinoma: Spiral CT assessment with surgical and pathologic correlation
13. The results of treatment of 4389 cases of preclinical cervical squamous carcinoma
14. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer
15. Exploring the new world of the genome with DNA microarrays
16. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
17. Risk of pancreatic cancer following diabetes mellitus: A nationwide cohort study in Sweden
18. Morphological lesions associated with human primary invasive menendocrine pancreas cancer
19. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms
20. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma
21. An approach to proteomic analysis of human tumors
22. A gene hypermethylation profile of human cancer
23. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
24. Diabetes mellitus as a risk factor for pancreatic cancer: A meta-analysis
25. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR
26. Multidetector CT angiography in the evaluation of pancreatic carcinoma: Preliminary observations
27. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids
28. Sample preparation of human tumors prior to two-dimensional electrophoresis of proteins
29. Varying grades of epithelial atypia in the pancreatic ducts of humans: Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen
30. Comparative study of CA242 and CA19 9 in chronic pancreatitis
31. Very high risk of cancer in familial Peutz-Jeghers syndrome
32. Increased risk of cancer in the Peutz-Jeghers syndrome
33. Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids
34. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: Evidence and implications
35. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology: Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER +
36. Increased risk of pancreatic cancer in melanoma-prone kindreds with p161NK4 mutations
37. Detection of aberrantly methylated bMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer
38. Cancer statistics, 2000
39. Detection of bloodborne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers
40. Diabetes and the risk of pancreatic cancer
41. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
42. Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions
43. Genetics of pancreatic cancer: From genes to families
44. K-ras oncogene activation adenocarcinoma of the human pancreas: A study of 82 carcinomas using it combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization
45. New desorption strategies for the mass spectrometric analysis of macromolecules
46. Alpha-fetoprotein gene expression: Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells
47. Telomerase activity for the preoperative diagnosis of pancreatic cancer
48. Detection of mitochondrial DNA mutations in pancreatic cancer offers a “mass” ive advantage over detection of nuclear DNA mutations
49. Specific association of human telomerase activity with immortal cells and cancer
50. Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis
51. Relation of pancreatic duct hyperplasia to carcinoma
52. Repeated screening for colorectal cancer with fecal occult blood test: A prospective randomized study at Funen. Denmark
53. Randomised study of screening for colorectal cancer with faecal-occult-blood test
54. Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin
55. Bactericidal domain of lactoferrin: Detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry
56. K-Ras mutations and benign pancreatic disease
57. Pancreatitis and the risk of pancreatic cancer
58. Hereditary pancreatitis and the risk of pancreatic cancer
59. Ductal lesions in patients with chronic pancreatitis show K-ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53
60. Allelic loss is often the first hit in the biallelic inactivation of the p53 and dpc4 genes during pancreatic carcinogenesis
61. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium
62. Familial pancreatic cancer: Clinicopathologic study of 18 nuclear families
63. Familial pancreatic cancer: A review
64. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study
65. Recent advancements in surface-enhanced laser desorption/ionization- time of flight-mass spectrometry
66. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
67. A prospective study of K-ras mutations in the plasma or pancreatic cancer patients
68. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays
69. Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide gel electrophoresis
70. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines
71. Psoriasin (S100A7): A putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas
72. Predieting lung cancer by detecting aberrant promoter methylation in sputum
73. Proteomics to study genes and genomes
74. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
75. Molecular portraits of human breast tumours
76. Specific sample preparation in colorectal cancer
77. CA 19 9 in pancreatic cancer
78. Promoter hypermethylation patterns or p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients
79. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography: Comparison with conventional sonography, computed tomography, and angiography
80. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
81. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification
82. Cigarette smoking and pancreas cancer: A case-control study based on direct interviews
83. Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity
84. Pancreatic duct hyperplasia and cancer
85. New ways to probe the molecules of life
86. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers
87. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer
88. Telomerase activity in pancreatic juice differentiates, ductal carcinoma from adenoma and pancreatitis
89. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis
90. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
91. K-ras mutation in focal proliferative lesions of human pancreas
92. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer
93. Neoplastic discases in families of breast cancer patients
94. Identification and characterization of differentially methylated CpG islands in pancreatic cancer
95. Hypennethylation of multiple genes in pancreatic adenocarcinoma
96. Serial analysis of gene expression
97. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine
98. Genetic alterations during colorectal-tumor development
99. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers or epithelial ovarian cancer
100. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: Loss of intranuclear expression
101. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity
102. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
103. ProteinChip surface enhanced desorption/ionization (SELD1) mass spectometry: A novel protein biochip technology detection of prostate cancer biomarkers in complex protein mixtures
104. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
105. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features
106. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability
107. Genetic progression and divergence in pancreatic carcinoma
108. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients
109. Clinical applications of two-dimensional electrophoresis
110. Identifying markers for pancreatic cancer by gene expression analysis